[Ovarian and para-aortic recurrence from cervix cancer detected by PET/CT]

Rev Esp Med Nucl. 2006 Jan-Feb;25(1):31-4. doi: 10.1157/13083341.
[Article in Spanish]

Abstract

We present the case of a 34-year-old woman diagnosed of an adenosquamous carcinoma of the uterine cervix, stage IIB of the FIGO classification (International Federation of Gynecology and Obstetrics), treated with quimiotherapy, radiotheraphy and brachytheraphy with posterior hysterectomy. A recurrence of the disease was suspected due to the progressive rise of CEA levels. A PET/CT revealed abnormal foci in both ovaries, that had been transposed to avoid lesions due to radiation, and in a left para-aortic adenopathy. The diagnosis of recurrence in these sites was confirmed by biopsy. PET with FDG (F18-fluorodeoxyglucose) is useful in the staging of primary tumour and in the detection of recurrence in uterine cervical carcinoma, with better sensitivity and specificity than CT and MRI. PET/CT improves anatomic resolution and helps to resolve the origin of unclear foci like in the case presented in which ovaries were not in their normal situation due to transposition.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brachytherapy
  • Carcinoma, Adenosquamous / diagnostic imaging
  • Carcinoma, Adenosquamous / secondary*
  • Carcinoma, Adenosquamous / therapy
  • Carcinoma, Squamous Cell / diagnosis
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Female
  • Humans
  • Hysterectomy
  • Lymphatic Metastasis / diagnosis*
  • Lymphatic Metastasis / diagnostic imaging
  • Ovarian Neoplasms / diagnostic imaging
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / secondary*
  • Positron-Emission Tomography*
  • Radiotherapy, Adjuvant
  • Tomography, X-Ray Computed*
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / therapy

Substances

  • Antineoplastic Agents, Alkylating
  • Cisplatin